Live from the NIH registry
Studies recruiting near Santa Clarita right now
Top 25 of 2,390 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente - Panorama City — Panorama City, California (13.6 mi)
· Sponsor: SWOG Cancer Research Network
Assessing Improvements in Mood and Sleep Trial
Depression, Suicidality
N/A
Interventional 420 participants sought
The Regents of the University of California, Los Angeles — Los Angeles, California (29.1 mi)
· Sponsor: University of Pittsburgh
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
UCLA Care — Los Angeles, California (29.1 mi)
· Sponsor: Westat
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0135) — Burbank, California (19.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Beverly Hills Cancer Center — Beverly Hills, California (24.4 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Global Research Management — Glendale, California (23.5 mi)
· Sponsor: Boehringer Ingelheim
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
California Eye Specialists Medical group Inc. — Pasadena, California (27.4 mi)
· Sponsor: Genentech, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital Los Angeles — Los Angeles, California (29.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Clinical Research Institute, LCC — Los Angeles, California (29.1 mi)
· Sponsor: AbbVie
Study Evaluating the Quality and Effects of Lion's Mane Product on Cognitive Health
Cognitive Decline
N/A
Observational 150 participants sought
People Science — Los Angeles, California (29.1 mi)
· Sponsor: M2 Ingredients
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Glendale, California (23.5 mi)
· Sponsor: Daiichi Sankyo
Towards Restoring Complex Movement After Paralysis: Algorithm Development With Healthy Participants
Movement Disorders, Neurorehabilitation
N/A
Interventional 50 participants sought
UCLA Neural Engineering and Computation Lab — Los Angeles, California (29.1 mi)
· Sponsor: University of California, Los Angeles
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Narcolepsy Type 1
Phase 3
Interventional 150 participants sought
Alkermes Investigational Site — Los Angeles, California (29.1 mi)
· Sponsor: Alkermes, Inc.
Pharmacogenomics of Asparaginase Induced Hepatotoxicity
Acute Lymphoblastic Leukemia
N/A
Observational 500 participants sought
Los Angeles General Medical Center — Los Angeles, California (29.1 mi)
· Sponsor: University of Southern California
PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy
Postpartum Hypertension (PPHT)
Phase 4
Interventional 110 participants sought
UCLA Ronald Reagan — Los Angeles, California (29.1 mi)
· Sponsor: University of California, Los Angeles
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
UCLA Santa Monica Hematology Oncology — Santa Monica, California (27.5 mi)
· Sponsor: Astellas Pharma Inc
Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis
Children With Medical Complexity (CMC), Multiple Chronic Conditions
N/A
Interventional 110 participants sought
Children's Hospital Los Angeles — Los Angeles, California (29.1 mi)
· Sponsor: University of Utah
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Severe Tricuspid Regurgitation
N/A
Interventional 1,186 participants sought
Los Robles Hospital & Medical Center — Thousand Oaks, California (25.9 mi)
· Sponsor: Medtronic Cardiovascular
A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
Hypoparathyroidism
Phase 3
Interventional 160 participants sought
MBX Biosciences Investigational Site — Los Angeles, California (29.1 mi)
· Sponsor: MBX Biosciences
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Amyotrophic Lateral Sclerosis
Phase 3
Interventional 495 participants sought
University of Southern California — Los Angeles, California (29.1 mi)
· Sponsor: AB Science
Housing Transitions QUERI
Homelessness
Phase 1
Interventional 153 participants sought
VA Greater Los Angeles Healthcare System, West Los Angeles, CA — West Los Angeles, California (25.9 mi)
· Sponsor: VA Office of Research and Development
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Solid Tumor, Adult, Metastatic Breast Cancer
Phase 1
Interventional 392 participants sought
University of California Los Angeles — Los Angeles, California (29.1 mi)
· Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Hepatocellular Carcinoma
Phase 1, Phase 2
Interventional 304 participants sought
Research Site — Los Angeles, California (29.1 mi)
· Sponsor: AstraZeneca
Bridge the Gap (BTG) - Black Youth Group
Suicide Prevention
N/A
Interventional 16 participants sought
Children's Hospital Los Angeles — Los Angeles, California (29.1 mi)
· Sponsor: Children's Hospital Los Angeles
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Sylmar, California (8.0 mi)
· Sponsor: AstraZeneca